| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2018 | NEO Neogenomics Inc | Johnson Kevin C | Director | Buy | 26,000 | $11.60 | $301,600.00 | +33.4% | |
| Dec 20, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $10.40 | $156,000.00 | -2.7% | |
| Dec 19, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 10,000 | $10.78 | $107,800.00 | -1.8% | |
| Dec 14, 2018 | BIO Bio-Rad Laboratories, Inc. | Tsingos Christine A | EVP And CFO | Sell | 1,411 | $248.00 | $349,928.00 | -17.4% | |
| Dec 14, 2018 | WAT Waters Corp /de/ | Harrington Michael C | SVP, Global Markets | Sell | 1,131 | $189.53 | $214,358.43 | -100% | |
| Dec 14, 2018 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 392 | $248.03 | $97,227.64 | -10.3% | |
| Dec 13, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 5,000 | $12.68 | $63,400.00 | -0.9% | |
| Dec 12, 2018 | BIO Bio-Rad Laboratories, Inc. | Stark James R | VP, Corporate Controller | Sell | 848 | $254.77 | $216,044.96 | -100% | |
| Dec 11, 2018 | BIO Bio-Rad Laboratories, Inc. | Tumolo Annette71 | Executive Vice President | Sell | 2,376 | $254.51 | $604,704.00 | -44.1% | |
| Dec 11, 2018 | WAT Waters Corp /de/ | Kelly Terrence P | SVP, President Ta Instruments | Sell | 21,028 | $190.07 | $3,996,817.33 | -42.1% | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,668 | $127.47 | $467,555.42 | - | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,120 | $127.10 | $523,650.06 | - | |
| Dec 10, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $12.57 | $188,550.00 | -2.5% | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,981 | $126.73 | $504,522.85 | - | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,668 | $128.25 | $470,415.88 | - | |
| Dec 10, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 8,000 | $12.13 | $97,076.80 | -13.2% | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 1,977 | $129.11 | $255,251.80 | - | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,308 | $126.41 | $544,566.58 | - | |
| Dec 10, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,401 | $126.05 | $428,689.74 | - | |
| Dec 7, 2018 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 9,500 | $241.45 | $2,293,775.00 | -21.5% | |
| Dec 6, 2018 | AWHL Aspira Women's Health Inc. | Beechey Robert Harry | Chief Financial Officer | Buy | 25,000 | $0.57 | $14,250.00 | +14.3% | |
| Dec 4, 2018 | IQV Iqvia Holdings Inc. | Connaughton John | Director | Sell | 767,574 | $123.72 | $94,964,255.28 | -20.5% | |
| Dec 4, 2018 | CRL Charles River Laboratories International, Inc. | Bertolini Robert J | Director | Sell | 3,440 | $133.77 | $460,154.47 | -0.4% | |
| Dec 4, 2018 | IQV Iqvia Holdings Inc. | Tpg Group Holdings (sbs) Advisors, Inc.86 | Director | Sell | 3,573,545 | $123.72 | $442,118,987.40 | -22.1% | |
| Dec 4, 2018 | CRL Charles River Laboratories International, Inc. | Bertolini Robert J | Director | Sell | 1,100 | $134.71 | $148,179.00 | -0.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.